SCHEMBL4434307

SCHEMBL4434307

CC(C)(O)C(C)(C)OB(O)c1nccc2ccccc12

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 1/20 0.44
TSHR P16473 1/20 0.44
CYP2C19 P33261 1/20 0.44
CFTR P13569 1/20 0.40
GOPC Q9HD26 1/20 0.40
CYP2A6 P11509 1/20 0.40
PLAU P00749 2/20 0.37
F12 P00748 1/20 0.37
NCF1 P14598 1/20 0.37
NOS3 P29474 1/20 0.37
NOS1 P29475 1/20 0.37
NOS2 P35228 1/20 0.37
BACE1 P56817 1/20 0.37
NPC1 O15118 1/20 0.35
RAB9A P51151 1/20 0.35
PLG P00747 1/20 0.35
LMNA P02545 2/20 0.34
NCOA3 Q9Y6Q9 1/20 0.33
TRPA1 O75762 1/20 0.33
HRH4 Q9H3N8 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5953116 0.76 ALDH1A1 (0.36) CYP3A4TSHRCYP2C19CYP2A6RAB9A
SCHEMBL16010409 0.74 NCF1 (0.37) CYP3A4TSHRCYP2C19NCF1LMNA
SCHEMBL12098049 0.74 NPC1 (0.30) TSHRNPC1
SCHEMBL16334860 0.73 PTGS1 (0.33)
SCHEMBL1190802 0.72 PLAU (0.50) CYP3A4TSHRCYP2C19CFTRGOPC
SCHEMBL29350664 0.72 PLAU (0.50) CYP3A4TSHRCYP2C19CFTRGOPC
SCHEMBL782732 0.71 CYP11B2 (0.34) CYP3A4CYP2C19SSTR4
SCHEMBL476840 0.71 KDM4E (0.39) CYP3A4NPC1RAB9ALMNA
SCHEMBL478257 0.71 SMN1; SMN2 (0.36)
SCHEMBL22684748 0.70 MAPT (0.33)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2124913-A1 1-AMINOMETHYL- L- PHENYL- CYCLOHEXANE DERIVATIVES AS DDP-IV INHIBITORS Novartis AG (CH) 2009-12-02 EP disclosed
WO-2008077597-A1 1-AMINOMETHYL- L- PHENYL- CYCLOHEXANE DERIVATIVES AS DDP-IV INHIBITORS NOVARTIS AG (CH) 2008-07-03 WO disclosed